Lokavant Introduces First Source-Agnostic Data Engine to Drive Better Clinical Trial Decision-Making and Improve Performance
Retrieved on:
Wednesday, January 31, 2024
Software, Research, Professional Services, Pharmaceutical, Technology, Artificial Intelligence, Health Technology, Data Analytics, Clinical Trials, Science, Biotechnology, Health, Other Science, PRIZM, AI, ChromeOS, CDH, Clinical trial, RWD, Drug development, Digital, Artificial intelligence, EDC, Medidata Solutions, Specialization, American Opportunity Tax Credit, SCOPE, CTMS, Medical device
Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.
Key Points:
- Lokavant , the clinical trial intelligence platform company, announces PRIZM™ Clinical Data Hub (CDH), the industry’s source-agnostic clinical data hub to aid decision-making and improve trial performance with predictive analytics.
- The life sciences industry struggles to harness enough data to fuel AI for practical uses in clinical research.
- All trial data is harmonized in PRIZM which fuels Lokavant’s platform to provide a centralized view of trial performance in real time.
- The industry needs a reliable solution to distill and standardize all the various data sources to drive improved clinical trial decisions.